We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-17.1%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
-$1.36B
(-19%)
Cap. Flow
-$72.7M
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
17.58%
Holding
1,139
New
165
Increased
376
Reduced
380
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$58.3M |
| 2 |
CELG
Celgene Corp
CELG
|
+$27.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$23.3M |
| 4 |
TJX Companies
TJX
|
+$23.1M |
| 5 |
Synopsys
SNPS
|
+$19.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dell
DELL
|
+$45.2M |
| 2 |
Rockwell Automation
ROK
|
+$25.3M |
| 3 |
Accenture
ACN
|
+$24M |
| 4 |
Visteon
VC
|
+$23.4M |
| 5 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.85% |
| 2 | Financials | 17.71% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Healthcare | 11.49% |
| 5 | Industrials | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
501
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.66M | 0.03% |
129,629
+22,124
| +21% | +$336K |
|
|
CSGS
502
DELISTED
CSG Systems International
CSGS
| $1.65M | 0.03% |
51,827
+4,740
| +10% | +$166K |
|
503
Lexicon Pharmaceuticals
LXRX
$1.03B
| $1.64M | 0.03% |
247,090
+73,760
| +43% | +$598K |
|
504
Magnite
MGNI
$2.75B
| $1.64M | 0.03% |
439,930
-11,200
| -2% | -$42.8K |
|
505
Cigna
CI
$77.1B
| $1.62M | 0.03% |
8,530
-26,520
| -76% | -$5.53M |
|
|
506
Visteon
VC
$2.76B
| $1.62M | 0.03% |
26,876
-310,221
| -92% | -$23.4M |
|
507
MDU Resources
MDU
$4.4B
| $1.62M | 0.03% |
178,595
+9,230
| +5% | +$90.1K |
|
|
BDN
508
Brandywine Realty Trust
BDN
$544M
| $1.6M | 0.03% |
124,715
+104,515
| +517% | +$1.48M |
|
509
TD Synnex
SNX
$19.3B
| $1.6M | 0.03% |
39,698
-161,920
| -80% | -$6.41M |
|
510
Texas Capital Bancshares
TCBI
$4.29B
| $1.6M | 0.03% |
31,420
-14,780
| -32% | -$932K |
|
511
Kosmos Energy
KOS
$1.47B
| $1.6M | 0.03% |
+393,100
| New | +$2.43M |
|
512
Tilly's
TLYS
$116M
| $1.6M | 0.03% |
146,942
+75,542
| +106% | +$1.12M |
|
513
Southwest Gas
SWX
$6.69B
| $1.59M | 0.03% |
20,774
| – | – |
|
|
NBL
514
DELISTED
Noble Energy, Inc.
NBL
| $1.58M | 0.03% |
84,460
+11,770
| +16% | +$301K |
|
|
DRE
515
DELISTED
Duke Realty Corp.
DRE
| $1.57M | 0.03% |
60,770
-14,516
| -19% | -$403K |
|
|
AHT
516
Ashford Hospitality Trust
AHT
$21M
| $1.57M | 0.03% |
398
+147
| +59% | +$734K |
|
|
OPB
517
DELISTED
Opus Bank Common Stock
OPB
| $1.57M | 0.03% |
80,217
+14,300
| +22% | +$305K |
|
518
Berkshire Hathaway Class B
BRK.B
$1.07T
| $1.55M | 0.03% |
7,572
+240
| +3% | +$50.1K |
|
519
Essential Utilities
WTRG
$11.3B
| $1.54M | 0.03% |
45,200
+35,280
| +356% | +$1.22M |
|
520
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
| $1.54M | 0.03% |
5,080
-13,347
| -72% | -$4.44M |
|
521
Gilead Sciences
GILD
$164B
| $1.53M | 0.03% |
+24,430
| New | +$1.71M |
|
522
Valmont Industries
VMI
$9.5B
| $1.52M | 0.03% |
13,733
-7,262
| -35% | -$905K |
|
|
TCF
523
DELISTED
TCF Financial Corporation
TCF
| $1.52M | 0.03% |
78,000
+9,300
| +14% | +$201K |
|
524
WesBanco
WSBC
$3.95B
| $1.51M | 0.03% |
41,244
| – | – |
|
525
Powell Industries
POWL
$7.82B
| $1.51M | 0.03% |
181,098
-8,970
| -5% | -$88.9K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2018 Portfolio in Review
As of Q4 2018, Jacobs Levy Equity Management held 1,139 positions worth $5.69B, down 19% from $7.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management's Q4 2018 filing shows 165 new, 376 increased, 380 reduced and 175 closed positions. Its largest new stake was Starbucks: 930,980 shares worth $60M. The largest sale was Dell, an estimated $45.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q4 2018 buy was Starbucks: 930,980 shares worth $60M.
- Jacobs Levy Equity Management added most to Celgene Corp in Q4 2018, an estimated $27.6M increase.
- Jacobs Levy Equity Management's biggest Q4 2018 reduction was Accenture, cutting an estimated $24M.
- Jacobs Levy Equity Management fully exited Dell in Q4 2018, selling an estimated $45.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $5.69B portfolio in Q4 2018.
- Jacobs Levy Equity Management opened 165 new positions and closed 175 in Q4 2018.
- Jacobs Levy Equity Management's portfolio value fell 19% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2018, filed 14 Feb 2019.